links header



email icon EMAIL ARTICLE

oct links image Robert Robbins, MD
Stanford University School of Medicine, Stanford, CA, USA
Past President, ISHLT

Texas Medical Center Announces New President and Chief Executive Officer
September 15, 2012, Lisa Mayes, Texas Medical Center News

Effective November 5, 2012, Dr. Robert Robbins is the new president and chief executive officer for Texas Medical Center. Robert (Bobby) Robbins, M.D., who currently is professor and chairman of the Department of Cardiothoracic Surgery at Stanford and director of the Stanford Cardiovascular Institute, says he's a longtime fan of the leading-edge research and lifesaving treatments that take place every day in the Texas Medical Center. "I have great respect and admiration for what takes place in the Texas Medical Center," Robbins said, "and I’m humbled to have been selected and entrusted with this leadership position." Read more...

oct links image Gregor Warnecke, MD
Hannover Medical University, Hannover, GERMANY

Parents save son by each giving him a lung
September 13, 2012, The Local, German's News in English

A boy with cystic fibrosis is starting a new life after German doctors performed the country's first double living lung transplant, giving him a lung from each of his mother and father. Surgeons at the Hannover Medical University (MHH) performed a triple operation, using three operating rooms in parallel, with a lung being removed from each parent, and then implanted into 12-year-old Marius. "The operations went well, the parents were able to leave hospital after ten days," said Warnecke. Marius' operation lasted six hours. Read more...

oct links image Michael P Fischbein, MD
Stanford University School of Medicine, Stanford, CA, USA

Stanford Hospital Physicians Give Heart Patient a Second Chance
September 19, 2012, Stanford Hospitals & Clinics News

After four years of successful clinical trials with nearly 200 patients, Stanford had been approved by the FDA as the first facility in the Bay Area to be able to use a new device, the Edwards Sapien transcatheter heart valve, in patients who were not good candidates for the traditional surgical approach. "The device has really advanced the treatment of aortic stenosis with a team approach," Fischbein said, "with cardiologists and cardiac surgeons working together, bringing their experience to the table." Read more...

oct links image George Sokos, DO
West Penn Allegheny Health System, Pittsburgh, PA, USA

AGH Cardiovascular Researchers Target Key Pathway in Brain to Repair Failing Hearts
September 11, 2012, West Penn Allegheny Health System News

Allegheny General Hospital (AGH) is enrolling patients in a clinical trial exploring an investigational, implantable electrical stimulation device to determine whether the technology can not only relieve symptoms of congestive heart failure but slow the progression of this all-too-common disease that is the leading cause of hospital admissions in adults over age 65. "Congestive heart failure, when the heart becomes weakened and cannot pump as much blood as it should, is the most rapidly growing cardiovascular disorder in the United States," said George Sokos, DO, a heart failure cardiologist at AGH and principal investigator for the new clinical trial, known as INOVATE-HF. Read more...

oct links image Sunjay Kaushal, MD, PhD
University of Maryland School of Medicine, Baltimore, MD, USA

University of Maryland Study Suggests Neonatal Cardiac Stem Cells May Help Mend Children's Broken Hearts
September 12, 2012, University of Maryland SOM News & Events

Researchers at the University of Maryland School of Medicine, who are exploring novel ways to treat serious heart problems in children, have conducted the first direct comparison of the regenerative abilities of neonatal and adult-derived human cardiac stem cells. "The surprising finding is that the cells from neonates are extremely regenerative and perform better than adult stem cells," says the study's senor author, Sunjay Kaushal, MD, PhD, associate professor of surgery at the University of Maryland School of Medicine and director, pediatric cardiac surgery at the University of Maryland Medical Center. "We are extremely excited and hopeful that this new cell-based therapy can play an important role in the treatment of children with congenital heart disease, many of whom don't have other options." Read more...

oct links image Alexander Krupnick, MD
Washington University School of Medicine, St Louis, MO, USA

Key immune cell may play role in lung cancer susceptibility
September 20, 2012, Washington University in St Louis Newsroom

Why do many heavy smokers evade lung cancer while others who have never lit up die of the disease? The question has vexed scientists for decades. Now, new research at Washington University School of Medicine in St. Louis suggests a key immune cell may play a role in lung cancer susceptibility. "We want to know whether heavy smokers who don't get lung cancer have natural killer cells that are somehow better at destroying newly developing lung cancer cells," says Krupnick, associate professor of surgery. "And, by comparison, do patients who have never smoked but develop lung cancer have weak natural killer cells?" Read more...